We are live on
!
Find out more
MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$328M
1-Year Est. Return
9.77%
This Fund
S&P 500
This Quarter
Est. Return
+4.37%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.53B
AUM Growth
-$8.45B
(-53%)
Cap. Flow
-$9.27B
Cap. Flow
% of AUM
-123.16%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
2,587
New
127
Increased
54
Reduced
2,293
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$11.4M |
| 2 |
American Electric Power
AEP
|
+$5.7M |
| 3 |
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
|
+$4.35M |
| 4 |
Clorox
CLX
|
+$3.38M |
| 5 |
KLA
KLAC
|
+$3.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$277M |
| 2 |
Bank of America
BAC
|
+$216M |
| 3 |
Microsoft
MSFT
|
+$202M |
| 4 |
Amazon
AMZN
|
+$140M |
| 5 |
Meta Platforms (Facebook)
META
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.11% |
| 2 | Technology | 11.55% |
| 3 | Healthcare | 8.57% |
| 4 | Industrials | 7.86% |
| 5 | Consumer Discretionary | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Southside Bancshares
SBSI
$979M
| $308K | ﹤0.01% |
9,136
-9,575
| -51% | -$339K |
|
|
MAGN
1602
Magnera Corp
MAGN
$443M
| $308K | ﹤0.01% |
+1,104
| New | +$287K |
|
1603
TherapeuticsMD
TXMD
$24.1M
| $307K | ﹤0.01% |
1,017
-1,043
| -51% | -$290K |
|
|
INOV
1604
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $307K | ﹤0.01% |
20,483
-22,977
| -53% | -$365K |
|
|
HIFR
1605
DELISTED
InfraREIT, Inc.
HIFR
| $306K | ﹤0.01% |
16,468
-14,726
| -47% | -$313K |
|
|
BEAT
1606
DELISTED
BioTelemetry, Inc.
BEAT
| $306K | ﹤0.01% |
10,241
-9,291
| -48% | -$269K |
|
1607
Materion
MTRN
$5.9B
| $305K | ﹤0.01% |
6,284
-7,312
| -54% | -$348K |
|
|
GES
1608
DELISTED
Guess Inc
GES
| $304K | ﹤0.01% |
18,038
-25,749
| -59% | -$427K |
|
|
RDUS
1609
DELISTED
Radius Recycling
RDUS
| $303K | ﹤0.01% |
9,055
-10,213
| -53% | -$299K |
|
|
ACOR
1610
DELISTED
Acorda Therapeutics
ACOR
| $303K | ﹤0.01% |
118
-131
| -53% | -$372K |
|
|
UBNK
1611
DELISTED
United Financial Bancorp, Inc.
UBNK
| $303K | ﹤0.01% |
17,187
-15,924
| -48% | -$290K |
|
|
MSFG
1612
DELISTED
MainSource Financial Group Inc
MSFG
| $303K | ﹤0.01% |
8,353
-8,830
| -51% | -$331K |
|
1613
ICF International
ICFI
$1.6B
| $302K | ﹤0.01% |
5,760
-6,385
| -53% | -$344K |
|
1614
NMI Holdings
NMIH
$3.38B
| $302K | ﹤0.01% |
17,779
-20,848
| -54% | -$325K |
|
1615
Western Alliance Bancorporation
WAL
$8.92B
| $302K | ﹤0.01% |
5,338
-84
| -2% | -$4.68K |
|
|
DPLO
1616
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $302K | ﹤0.01% |
15,048
-16,962
| -53% | -$334K |
|
|
CRC
1617
DELISTED
California Resources Corporation
CRC
| $301K | ﹤0.01% |
15,478
-18,216
| -54% | -$256K |
|
|
TPC
1618
Tutor Perini Cor
TPC
$5.05B
| $300K | ﹤0.01% |
11,831
-15,106
| -56% | -$402K |
|
|
SASR
1619
DELISTED
Sandy Spring Bancorp Inc
SASR
| $300K | ﹤0.01% |
7,696
-7,977
| -51% | -$320K |
|
|
WRD
1620
DELISTED
WildHorse Resource Development
WRD
| $300K | ﹤0.01% |
16,318
-1,628
| -9% | -$24.5K |
|
1621
Casella Waste Systems
CWST
$5.79B
| $299K | ﹤0.01% |
+12,983
| New | +$256K |
|
1622
Heritage Financial
HFWA
$1.22B
| $299K | ﹤0.01% |
9,723
-9,002
| -48% | -$277K |
|
1623
Strategic Education
STRA
$1.81B
| $299K | ﹤0.01% |
3,333
-3,891
| -54% | -$359K |
|
|
DNR
1624
DELISTED
Denbury Resources, Inc.
DNR
| $299K | ﹤0.01% |
135,356
-90,261
| -40% | -$142K |
|
|
IPHS
1625
DELISTED
Innophos Holdings, Inc.
IPHS
| $299K | ﹤0.01% |
6,403
-6,796
| -51% | -$317K |
|
Similar funds
GWM
KSCM
AFS
BAM
ML
BCM
ECH
PCM
Metropolitan Life Insurance Company (MetLife)'s Q4 2017 Portfolio in Review
As of Q4 2017, Metropolitan Life Insurance Company (MetLife) held 2,587 positions worth $7.53B, down 53% from $16B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Metropolitan Life Insurance Company (MetLife) withdrew a net $9.27B in Q4 2017, closing 88 positions and reducing 2,293 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $89.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in CVS Health worth $11.4M.
- Metropolitan Life Insurance Company (MetLife)'s largest Q4 2017 buy was CVS Health: 157,105 shares worth $11.4M.
- Metropolitan Life Insurance Company (MetLife) added most to iShares National Muni Bond ETF in Q4 2017, an estimated $3M increase.
- Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2017 reduction was Apple, cutting an estimated $277M.
- Metropolitan Life Insurance Company (MetLife) fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, selling an estimated $89.8M.
- Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 33% of its $7.53B portfolio in Q4 2017.
- Metropolitan Life Insurance Company (MetLife) opened 127 new positions and closed 88 in Q4 2017.
- Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 53% quarter-over-quarter to $7.53B.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2017, filed 15 Feb 2018.